{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-328226","form_type":"8-K","ticker":"RANI","cik":"0001856725","company_name":"Rani Therapeutics Holdings, Inc.","filed_at":"2021-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.823139+00:00","generated_at":"2026-06-28T09:30:45.581759+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Rani Therapeutics elects Lyn Baranowski to Board, grants 31,695 stock options","bullets":["Lyn Baranowski elected as Director effective Nov 10, 2021; term expires at next annual meeting.","Appointed to Compensation Committee and Nominating and Corporate Governance Committee.","Granted options to purchase 31,695 shares of Class A common stock at $26.78 (closing price on grant date).","Options vest over 3 years: one-third at first anniversary, then monthly installments, subject to continuous service.","Ms. Baranowski has no arrangement with others for her election, and no material interest in transactions requiring disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-328226","json":"https://secwatch.observer/filing/0001193125-21-328226.json","markdown":"https://secwatch.observer/filing/0001193125-21-328226.md","text":"https://secwatch.observer/filing/0001193125-21-328226.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1856725/000119312521328226/0001193125-21-328226-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1856725/000119312521328226/d626673d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T09:30:45.581759+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9790b0e08e","claim":"Lyn Baranowski was elected as Director at Rani Therapeutics Holdings, Inc..","evidence_excerpt":"On November 10, 2021, upon the recommendation of its Nominating and Corporate Governance Committee, the board of directors (the “Board”) of Rani Therapeutics Holdings, Inc. (the “Company”) elected Lyn Baranowski as a Director, effective immediately, with a term expiring at the Company’s next annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1856725/000119312521328226/0001193125-21-328226-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}